Wednesday, March 06, 2024 8:09:09 PM
Firstly, you should be applauded for your enquiring mind, for it is from only such debate that truly meaningful advancements are made in the Neuro scientific community.
Well, certainly from where we were 10-20 years ago.
I for one fully support the individual genomic profiling of each patient’s tumour, then adapting the treatment to match that dna signature.
The cure for GBM4 will never come from an ‘outside in approach’, such is the case with DCVAX.
Anyway, for the intellectually curious, I show my brain abscess in my right temporal lobe.
https://investorshub.advfn.com/uimage/uploads/2024/3/6/yltjlF0115E8F-038C-4529-B419-D60D114B47BC.jpeg
Isn’t this more interesting than just waiting for a 2 cent rise in stock price ?
Well, certainly from where we were 10-20 years ago.
I for one fully support the individual genomic profiling of each patient’s tumour, then adapting the treatment to match that dna signature.
The cure for GBM4 will never come from an ‘outside in approach’, such is the case with DCVAX.
Anyway, for the intellectually curious, I show my brain abscess in my right temporal lobe.
https://investorshub.advfn.com/uimage/uploads/2024/3/6/yltjlF0115E8F-038C-4529-B419-D60D114B47BC.jpeg
Isn’t this more interesting than just waiting for a 2 cent rise in stock price ?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
